CXCL8 and CCL20 enhance osteoclastogenesis via modulation of cytokine production by human primary osteoblasts

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Pathak, Janak L ^a,b   Bakker, Astrid D ^a   Verschueren, Patrick ^b   Lems, Willem F ^c   Luyten, Frank P ^b   Klein Nulend, Jenneke ^a   Bravenboer, Nathalie ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; INTERLEUKIN 6; INTERLEUKIN 8; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; CCL20 PROTEIN, HUMAN; CCR6 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR1; CONDITIONED MEDIUM; CYTOKINE; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; SCLEROPROTEIN; TUMOR NECROSIS FACTOR;

ADULT; AGED; ALP GENE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; KI67 GENE; MALE; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOPOROSIS; PRIMARY CELL CULTURE; RHEUMATOID ARTHRITIS; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BONE REMODELING; CELL CULTURE; CELL DIVISION; COMPLICATION; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; OSTEOLYSIS; PATHOPHYSIOLOGY; PHARMACOLOGY; PHYSIOLOGY;

AGED; ARTHRITIS, RHEUMATOID; BONE REMODELING; BONE RESORPTION; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHEMOKINE CCL20; CULTURE MEDIA, CONDITIONED; CYTOKINES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; RECEPTORS, CCR6; RECEPTORS, INTERLEUKIN-8A; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84939145811     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131041     Document Type: Article

References (48)

1. Mielants H, Van den Bosch F. Extra-articular manifestations. Clin Exp Rheumatol 2009;27:S56-S61. PMID:19822047
2. Hela S, Nihel M, Faten L, Monia F, Jalel B, Azza F, et al. Osteoporosis and Crohn's disease. Joint Bone Spine 2005;72:403-407. PMID:16112594
3. Vis M, Güler-Yüksel, Lems WF. Can bone loss in rheumatoid arthritis be prevented? Osteoporos Int 2013;10:2541-2553. doi:10.1007/s00198-013-2334-5 PMID:23775419
4. Haugeberg G. Focal and generalized bone loss in rheumatoid arthritis: separate or similar concepts? Nat Clin Pract Rheumatol 2008;4:402-403. doi:10.1038/ncprheum0843 PMID:18594493
5. Pathak JL, Bravenboer N, Verschueren P, Lems WF, Luyten FP, Klein-Nulend J et al. Inflammatory factors in the circulation of patients with active rheumatoid arthritis stimulate osteoclastogenesis via endogenous cytokine production by osteoblasts. Osteoporos Int 2014;25:2453-2463. doi:10.1007/s00198-014-2779-1 PMID:25027107
6. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 1996;14:397-440. PMID:8717520
7. Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, et al. Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblastlike synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs. J Rheumatol 2009;36:2397-2402. doi:10.3899/jrheum.090132 PMID:19797510
8. Kuan WP, Tam LS, Wong CK, Ko FW, Li T, Zhu T, et al. CXCL 9 and CXCL 10 as sensitive markers of disease activity in patients with rheumatoid arthritis. J Rheumatol 2010;37:257-264. doi:10.3899/jrheum.090769 PMID:20032101
9. Chaudhary LR, Spelsberg TC, Riggs BL. Production of various cytokines by normal human osteoblastlike cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol. Endocrinology 1992;130:2528-2534. PMID:1572280
10. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1beta and tumor necrosis factor-alpha but not interleukin-6 stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999;25:255-259. PMID:10495128
11. Shigeyama Y, Pap T, Kunzler P, Simmen BR, Gay RE, Gay S. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthr Rheum 2000;43:2523-2530. PMID:11083276
12. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalized bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-27. PMID:7912297
13. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008;118:3537-3545. doi:10.1172/JCI36389 PMID:18982160
14. Schett G, Gravallese E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol 2012;8:656-664. doi:10.1038/nrrheum.2012.153 PMID:23007741
15. Bakker AD, Silva VC, Krishnan R, Bacabac RG, Blaauboer ME, Lin YC, et al. Tumor necrosis factor alpha and interleukin-1beta modulate calcium and nitric oxide signaling in mechanically stimulated osteocytes. Arthr Rheum 2009;11:3336-3345. doi:10.1002/art.24920 PMID:19877030
16. Mackay CR. Chemokines: Immunology's high impact factors. Nat Immunol 2001;2:95-101. PMID:11175800
17. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Ann Rev Immunol 2000;18:217-242.
18. Lisignoli G, Toneguzzi S, Piacentini A, Cattini L, Lenti A, Tschon M, et al. Human osteoblasts express functional CXC chemokine receptors 3 and 5: activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and beta-N-acetylhexosaminidase release. J Cell Physiol 2003;194:71-79. PMID:12447991
19. Lisignoli G, Piacentini A, Cristino S, Grassi F, Cavallo C, Cattini L, et al. CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients. J Cell Physiol 2007;210:798-806. PMID:17133360
20. Lisignoli G, Manferdini C, Codeluppi K, Piacentini A, Grassi F, Cattini L, et al. CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups. J Cell Physiol 2009;221:154-160. doi:10.1002/jcp. 21839 PMID:19492413
21. Yano S, Mentaverri R, Kanuparthi D, Bandyopadhyay S, Rivera A, Brown EM, et al. Functional expression of beta-chemokine receptors in osteoblasts: role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts. Endocrinology 2005;146:2324-2335. PMID:15718270
22. Schlenk J, Lorenz HM, Haas JP, Herrmann M, Hohenberger G, Kalden JR, et al. Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis. J Rheumatol 2005;32:2291-2298. PMID:16331752
23. Aerts NE, De Knop KJ, Leysen J, Ebo DG, Bridts CH, Weyler JJ, et al. Increased IL-17 production by peripheral T helper cells after tumor necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. Rheumatol 2010;49:2264-2272.
24. Klein-Nulend J, Sterck JG, Semeins CM, Lips P, Joldersma M, Baart JA, et al. Donor age and mechanosensitivity of human bone cells. Osteoporos Int 2002;13:137-146. PMID:11908490
25. Oostlander AE, Bravenboer N, van Essen HW, Klein-Nulend J, Lems WF, Schulten BA, et al. Bone cells from patients with quiescent Crohn's disease show a reduced growth potential and an impeded maturation. J Cell Biochem 2012;113:2424-2431. doi:10.1002/jcb.24119 PMID:22535626
26. Bloemen V, de Vries TJ, Schoenmaker T, Everts V. Intercellular adhesion molecule-1 clusters during osteoclastogenesis. Biochem Biophys Res Commun 2009;385:640-645. doi:10.1016/j.bbrc.2009.05. 145 PMID:19501575
27. de Vries TJ, Mullender MG, van Duin MA, Semeins CM, James N, Green TP, et al. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts. Mol Cancer Res 2009;7:476-488. doi:10.1158/1541-7786. MCR-08-0219 PMID:19372577
28. Sterck JG, Klein-Nulend J, Lips P, Burger EH. Response of normal and osteoporotic human bone cells to mechanical stress in vitro. Am J Physol 1998;274:E1113-1120. PMID:9611164
29. Klein-Nulend J, Helfrich MH, Sterck JG, MacPherson H, Joldersma M, Ralston SH, et al. Nitric oxide response to shear stress by human bone cell cultures is endothelial nitric oxide synthase dependent. Biochem Biophys Res Commun 1998;250:108-114. PMID:9735341
30. Bakker AD, Klein-Nulend J, Tanck E, Albers GH, Lips P, Burger EH. Additive effects of estrogen and mechanical stress on nitric oxide and prostaglandin E2 production by bone cells from osteoporotic donors. Osteoporos Int 2005;16:983-989. PMID:15551057
31. Bakker AD, Klein-Nulend J, Tanck E, Heyligers IC, Albers GH, Lips P, et al. Different responsiveness to mechanical stress of bone cells from osteoporotic versus osteoarthritic donors. Osteoporos Int 2006;17:827-833. PMID:16565787
32. Kim CH, Kang BS, Lee TK, Park WH, Kim JK, Park YG, et al. IL-1beta regulates cellular proliferation, prostaglandin E2 synthesis, plasminogen activator activity, osteocalcin production, and bone resorptive activity of the mouse calvarial bone cells. Immunopharmacol Immunotoxicol 2002;24:395-407. PMID:12375736
33. Gilbert L, He X, Farmer P, Boden S, Kozlowaski M, Rubin J, et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 2000;141:3956-3964. PMID:11089525
34. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986;319:516-518. PMID:3511389
35. Wilson SR, Peters C, Saftig P, Brömme D. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. J Biol Chem 2009;284:2584-2592. doi:10.1074/jbc. M805280200 PMID:19028686
36. David M, Machuca-Gayet I, Kikuta J, Ottewell P, Mima F, Leblanc R, et al. Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity. J Biol Chem 2014;289:6551-6564. doi:10.1074/jbc. M113.533232 PMID:24429286
37. Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001;104:205-215. PMID:11207362
38. Okamoto F, Kajiya H, Toh K, Uchida S, Yoshikawa M, Sasaki S et al. Intracellular ClC-3 chloride channels promote bone resorption in vitro through organelle acidification in mouse osteoclasts. Am J Physiol Cell Physiol 2008;294:C693-C701. doi:10.1152/ajpcell.00251.2007 PMID:18234851
39. Lee AY, Körner H. CCR6 and CCL20: emerging players in the pathogenesis of rheumatoid arthritis. Immunol Cell Biol 2014;92:354-358. doi:10.1038/icb.2013.97 PMID:24394994
40. De Benedetti F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Longo M, et al. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthr Rheum 2006;54:3551-3563.
41. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthr Res 2002;4:S233-S242.
42. Le Goff B, Blanchard F, Berthelot JM, Heymann D, Maugars Y. Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis. Jt Bone Spine 2010;77:201-205.
43. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999;20:345-357. PMID:10368775
44. Endo H, Akahoshi T, Takagishi K, Kashiwazaki S, Matsushima K. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 1991;10:245-252. PMID:1932367
45. Kraan MC, Patel DD, Haringman JJ, Smith MD, Weedon H, Ahern MJ et al. The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8). Arthritis Res 2001;3:65-71. PMID:11178128
46. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 1994;56:559-564. PMID:7964163
47. Min SH, Wang Y, Gonsiorek W, Anilkumar G, Kozlowski J, Lundell D, et al. Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis. Biochem Biophys Res Commun 2010;391:1080-1086. doi:10.1016/j.bbrc.2009.12.025 PMID:20004647
48. Kochi Y, Okada Y, Suzuki A, Ikari K, Terao C, Takahashi A, et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 2010;42:515-519. doi:10.1038/ng.583 PMID:20453841